Pharma Journalist -

Building on the success of its launch last year SMi Group are proud to presents the 2nd Injectable Drug Delivery Conference and exhibition. Conference Overview: The global…
Read More...

Velabs Therapeutics, specializing in the fast generation of functional therapeutic antibodies, announced that it has entered into a collaboration agreement with BioMed X Innovation…
Read More...

Regeneron Pharmaceuticals and Sanofi have restructured their global Immuno-oncology Discovery and Development Agreement for new immuno-oncology cancer treatments. The 2015 Agreement was…
Read More...

The Janssen Pharmaceutical Companies of Johnson & Johnson announced the submission of a Group Type II Variation Application to the European Medicines Agency (EMA) seeking approval…
Read More...

CytoReason announced that it has entered into a collaboration agreement with Pfizer that will leverage CytoReason’s cell-centered models of the immune system. CytoReason will receive…
Read More...

SMi presents its 13th annual Parallel Trade conference happening next month. The highly anticipated event provides the perfect platform for industry experts to come together and share…
Read More...

GE Healthcare and Vanderbilt University Medical Center (VUMC) announced a five-year partnership to enable safer and more precise cancer immunotherapies. Multiple diagnostic tools will…
Read More...

AmpliPhi Biosciences Corporation and C3J Therapeutics announced that the companies have entered into a definitive agreement under which a wholly owned subsidiary of AmpliPhi will merge…
Read More...

Personal invitations were sent in December 2018 from the conference chairman Mr James Drinkwater, for the 2nd Annual Pharmaceutical Microbiology East Coast Conference, taking place in…
Read More...

SMi Report: An exclusive interview with Marine Marius, Scientist, Analytical Research and Development Europe, Sanofi Pasteur just ahead of the 8th Annual Pharmaceutical Microbiology UK…
Read More...